<SEC-DOCUMENT>0001438533-26-000046.txt : 20260521
<SEC-HEADER>0001438533-26-000046.hdr.sgml : 20260521
<ACCEPTANCE-DATETIME>20260521160719
ACCESSION NUMBER:		0001438533-26-000046
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		12
CONFORMED PERIOD OF REPORT:	20260519
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260521
DATE AS OF CHANGE:		20260521

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Travere Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001438533
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				262383102
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36257
		FILM NUMBER:		261008423

	BUSINESS ADDRESS:	
		STREET 1:		3611 VALLEY CENTRE DR
		STREET 2:		SUITE 300
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		888-969-7879

	MAIL ADDRESS:	
		STREET 1:		3611 VALLEY CENTRE DR
		STREET 2:		SUITE 300
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Retrophin, Inc.
		DATE OF NAME CHANGE:	20130220

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Desert Gateway, Inc.
		DATE OF NAME CHANGE:	20080625
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tvtx-20260519.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e4213-fcc3-7157-ba26-865ef646645a,g:95ac6c5e-3499-45ef-b384-3b61d525bc99,d:5f25194e2c7b44d39ae5d6afa1b4d51a-->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>tvtx-20260519</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0001438533</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-23">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="tvtx-20260519.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001438533</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2026-05-19</xbrli:startDate><xbrli:endDate>2026-05-19</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i5f25194e2c7b44d39ae5d6afa1b4d51a_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:3pt"><span><br/></span></div></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:13pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:13pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-bottom:3pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:13pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:13pt;font-weight:700;line-height:120%">Current Report</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d)of the Securities Exchange Act of 1934</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">May 19, 2026</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-bottom:3pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:13pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">TRAVERE THERAPEUTICS, INC.</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">___________________________</span></div><div style="margin-bottom:6pt;margin-top:3pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:32.135%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.085%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.138%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-36257</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">27-4842691</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">3611 Valley Centre Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-8">Suite 300</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">San Diego</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-10">CA</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">92130</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices, including Zip Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-12">888</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-13">969-7879</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(Registrant&#8217;s Telephone Number, including Area Code)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:2.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.801%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:2.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.801%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:2.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.801%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:2.999%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.801%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:3.578%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.580%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-18">Common Stock, par value $0.0001 per share</ix:nonNumeric></span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-19">TVTX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-20">The Nasdaq Global Market</ix:nonNumeric></span></div></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Emerging growth company  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-21">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#168;</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:3pt"><span><br/></span></div></div></div><div id="i5f25194e2c7b44d39ae5d6afa1b4d51a_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:3pt"><span><br/></span></div></div><div style="margin-bottom:10pt;margin-top:9pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:13pt;font-weight:700;line-height:120%">Item 5.02&#160;&#160;&#160;&#160;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">As discussed below in Item 5.07, Travere Therapeutics, Inc. (the &#8220;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:112%">Company</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8221;) held its 2026 Annual Meeting of Stockholders (the &#8220;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:112%">Annual Meeting</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8221;) at which the Company&#8217;s stockholders approved the Company&#8217;s 2018 Equity Incentive Plan, as amended (the &#8220;</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-style:italic;font-weight:700;line-height:112%">2018 Plan</span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">&#8221;), to increase the number of shares of common stock authorized for issuance thereunder by 3,000,000 shares. A summary of the material terms of the 2018 Plan is set forth in the Company&#8217;s definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on April 6, 2026. That summary is qualified in its entirety by reference to the text of the 2018 Plan, which is filed as Exhibit 99.1 hereto and incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i5f25194e2c7b44d39ae5d6afa1b4d51a_10"></div><div style="margin-bottom:10pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:13pt;font-weight:700;line-height:120%">Item 5.07 &#160;&#160;&#160;&#160;Submission of Matters to a Vote of Security Holders.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:112%">On May 19, 2026, the Company held the Annual Meeting. As of March 23, 2026, the record date for the Annual Meeting, 92,369,812 shares of common stock were outstanding and entitled to vote at the Annual Meeting. At the Annual Meeting, 81,108,473 shares of common stock were present in person or represented by proxy for the five proposals summarized below.</span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#4c4c4c;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Proposal 1: Election of Directors</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company&#8217;s stockholders elected the ten persons listed below to serve until the Company&#8217;s 2027 Annual Meeting of Stockholders. The final voting results are as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:39.895%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.080%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.080%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Votes For</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Votes Withheld</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Broker Non-Votes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Roy D. Baynes, M.D., Ph.D.</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66,479,999</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,338,149</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,290,327</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Suzanne Bruhn, Ph.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,711,994</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,106,154</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,290,327</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Timothy Coughlin</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,695,965</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,122,183</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,290,327</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eric Dube, Ph.D.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,095,860</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">722,288</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,290,327</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gary Lyons</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,208,952</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,609,196</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,290,327</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Jeffrey Meckler</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,469,263</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,348,885</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,290,327</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">John A. Orwin</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,657,472</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,160,676</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,290,327</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sandra Poole</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,551,138</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,267,010</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,290,327</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ron Squarer</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,767,455</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,050,693</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,290,327</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ruth Williams-Brinkley</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,764,679</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,053,469</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,290,327</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#4c4c4c;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Proposal 2: Approval of the Company&#8217;s 2018 Equity Incentive Plan, as amended</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company&#8217;s stockholders approved the 2018 Plan, as amended, to increase the number of&#160;shares of common stock authorized for issuance thereunder by 3,000,000. The final voting results are as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:78.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.081%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Votes For</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">72,998,395</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Votes Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,787,402</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Abstentions</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32,347</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Broker Non-Votes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,290,327</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#4c4c4c;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Proposal 3: Approval, on an advisory basis, of the compensation of the Company&#8217;s named executive officers</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company&#8217;s stockholders approved, on an advisory basis, the compensation of the Company&#8217;s named executive officers. The final voting results are as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:79.134%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.934%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Votes For</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">73,711,670</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Votes Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,073,324</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Abstentions</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,152</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Broker Non-Votes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,290,327</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#4c4c4c;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Proposal 4: Indication, on an advisory basis, of the preferred frequency of stockholder advisory votes on the compensation of the Company&#8217;s named executive officers</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company&#8217;s stockholders indicated, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company&#8217;s named executive officers. The final voting results are as follows:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:3pt"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:3pt"><span><br/></span></div></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:79.134%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.934%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">One Year</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">75,003,558</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Two Years</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,996</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Years</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">766,756</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Abstentions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,836</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Broker Non-Votes</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,290,327</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#4c4c4c;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Proposal 5: Ratification of the Selection of Independent Registered Public Accounting Firm</span></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">The Company&#8217;s stockholders ratified the selection by the Audit Committee of Ernst &amp; Young LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2026. The final voting results are as follows:</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:79.134%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.934%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Votes For</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">80,708,265</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Votes Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">120,699</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Abstentions</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">279,509</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Broker Non-Votes</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div id="i5f25194e2c7b44d39ae5d6afa1b4d51a_13"></div><div style="-sec-extract:summary;margin-bottom:10pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:13pt;font-weight:700;line-height:120%">Item 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Exhibits </span></div><div style="margin-bottom:6pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:88.521%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex991_8-kx20260519eip.htm">Travere Therapeutics, Inc. 2018 Equity Incentive Plan, as amended.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:3pt"><span><br/></span></div></div></div><div id="i5f25194e2c7b44d39ae5d6afa1b4d51a_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-bottom:6pt;margin-top:3pt"><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.514%"><tr><td style="width:0.1%"/><td style="width:2.048%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.048%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:42.678%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.849%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:37.430%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRAVERE THERAPEUTICS, INC.</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Dated: May 21, 2026</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">/s/ Elizabeth E. Reed</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Elizabeth E. Reed</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Chief Legal Officer, General Counsel &amp; Secretary</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;margin-top:3pt"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991_8-kx20260519eip.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2026 Workiva -->
<title>Document</title></head><body><div id="i51540a3ce96c40d294b626009a1d8929_1"></div><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:right;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:161%">EXHIBIT 99.1</font></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">2018 Equity Incentive Plan</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Adopted by the Board of Directors&#58; April 1, 2018</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Approved by the Stockholders&#58; May 9, 2018</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Amended by the Board of Directors&#58; April 1, 2019</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Approved by the Stockholders&#58; May 8, 2019</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Amended by the Board of Directors&#58; April 8, 2020</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Approved by the Stockholders&#58; May 15, 2020</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Amended by the Board of Directors&#58;  April 6, 2021</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Approved by the Stockholders&#58; May 14, 2021</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Amended by the Board of Directors&#58;  April 1, 2022</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Approved by the Stockholders&#58; May 11, 2022</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Amended by the Board of Directors&#58;  April 13, 2023</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Approved by the Stockholders&#58; May 17, 2023</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Amended by the Board of Directors&#58; March 25, 2024</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Approved by the Stockholders&#58; May 8, 2024</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Amended by the Board of Directors&#58; March 28, 2025</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Approved by the Stockholders&#58; May 15, 2025</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Amended by the Board of Directors&#58; March 29, 2026</font></div><div style="margin-top:3pt;text-align:center"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Approved by the Stockholders&#58; May 19, 2026</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:18pt"><font><br></font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">1.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:11.16pt">General</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Successor to and Continuation of Prior Plans.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The Plan is intended as the successor to and continuation of the Travere Therapeutics, Inc. 2015 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">2015 Plan</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;) and the Travere Therapeutics, Inc. 2014 Incentive Compensation Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">2014 Plan</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;, and together with the 2015 Plan, the &#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Prior Plans</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;). Following the Effective Date, no additional stock awards may be granted under the Prior Plans. Any unallocated shares remaining available for grant under the Prior Plans as of 12&#58;01 a.m., Pacific Time on the Effective Date (the &#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Prior Plans&#8217; Available Reserve</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;) will cease to be available under such Prior Plans at such time and will be added to the Share Reserve (as further described in Section 3(a) below) and be then immediately available for grant and issuance pursuant to Stock Awards granted under the Plan. In addition, from and after 12&#58;01 a.m., Pacific Time</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">on the Effective Date, all outstanding stock awards granted under the Prior Plans will remain subject to the terms of such Prior Plans, as applicable&#59; </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">provided, however</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, that any shares subject to outstanding stock awards granted under the Prior Plans that (i) expire or terminate for any reason prior to exercise or settlement, or (ii) are forfeited, cancelled or otherwise returned to the Company because of the failure to meet a contingency or condition required for the vesting of such shares (collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Prior Plans&#8217; Returning Shares</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;) will immediately be added to the Share Reserve (as further described in Section 3(a) below) as and when such shares become Prior Plans&#8217; Returning Shares and become available for issuance pursuant to Awards granted hereunder. All Stock Awards granted on or after 12&#58;01 a.m., Pacific Time</font><font style="color:#0070c0;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">on the Effective Date will be subject to the terms of this Plan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Eligible Award Recipients.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Employees, Directors and Consultants are eligible to receive Stock Awards under the Plan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(c)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8.46pt">Available Stock Awards.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The Plan provides for the grant of the following types of Stock Awards&#58; (i) Incentive Stock Options, (ii) Nonstatutory Stock Options, (iii) Stock Appreciation Rights, (iv) Restricted Stock Awards, (v) Restricted Stock Unit Awards, (vi) Performance Stock Awards, and (vii) Other Stock Awards.</font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(d)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Purpose.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The Plan, through the granting of Stock Awards, is intended to help the Company and any Affiliate secure and retain the services of eligible award recipients, provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate and provide a means by which the eligible recipients may benefit from increases in value of the Common Stock.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">2.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:11.16pt">Administration</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Administration by Board.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The Board will administer the Plan. The Board may delegate administration of the Plan to a Committee or Committees, as provided in Section 2(c).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Powers of Board.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The Board will have the power, subject to, and within the limitations of, the express provisions of the Plan&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(i)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;To determine (A) who will be granted Stock Awards&#59; (B) when and how each Stock Award will be granted&#59; (C) what type of Stock Award will be granted&#59; (D) the provisions of each Stock Award (which need not be identical), including when a person will be permitted to exercise or otherwise receive cash or Common Stock under the Stock Award&#59; (E) the number of shares of Common Stock subject to, or the cash value of, a Stock Award&#59; and (F) the Fair Market Value applicable to a Stock Award.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(ii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;To construe and interpret the Plan and Stock Awards granted under it, and to establish, amend and revoke rules and regulations for administration of the Plan and Stock Awards. The Board, in the exercise of these powers, may correct any defect, omission or inconsistency in the Plan or in any Stock Award Agreement, in a manner and to the extent it will deem necessary or expedient to make the Plan or Stock Award fully effective.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(iii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;To settle all controversies regarding the Plan and Stock Awards granted under it.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(iv)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;To accelerate, in whole or in part, the time at which a Stock Award may be exercised or vest (or the time at which cash or shares of Common Stock may be issued in settlement thereof).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(v)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;To prohibit the exercise of any Option, SAR or other exercisable Stock Award during a period of up to thirty days prior to the consummation of any pending stock dividend, stock split, combination or exchange of shares, merger, consolidation or other distribution (other than normal cash dividends) of Company assets to stockholders, or any other change affecting the shares of Common Stock or the share price of the Common Stock including any Transaction, for reasons of administrative convenience. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(vi)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;To suspend or terminate the Plan at any time. Except as otherwise provided in the Plan or a Stock Award Agreement, suspension or termination of the Plan will not materially impair a Participant&#8217;s rights under the Participant&#8217;s then-outstanding Stock Award without the Participant&#8217;s written consent except as provided in subsection (viii) below.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(vii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;To amend the Plan in any respect the Board deems necessary or advisable, including, without limitation, by adopting amendments relating to Incentive Stock Options and certain nonqualified deferred compensation under Section 409A of the Code and&#47;or to make the Plan or Stock Awards granted under the Plan compliant with the requirements for Incentive Stock Options or exempt from or compliant with the requirements for nonqualified deferred compensation under Section 409A of the Code, subject to the limitations, if any, of applicable law. However, if required by applicable law or listing requirements, and except as provided in Section&#160;9(a) relating to Capitalization Adjustments, the Company will seek stockholder approval of any amendment of the Plan that (A)&#160;materially increases the number of shares of Common Stock available for issuance under the Plan, (B)&#160;materially expands the class of individuals eligible to receive Stock Awards under the Plan, (C)&#160;materially increases the benefits accruing to Participants under the Plan, (D) materially reduces the price at which shares of Common Stock may be issued or purchased under the Plan, or (E) materially expands the types of Stock Awards available for issuance under the Plan. Except as provided in the Plan (including Section 2(b)(viii)) or a Stock Award Agreement, no amendment of the Plan will materially impair a Participant&#8217;s rights under an outstanding Stock Award without the Participant&#8217;s written consent.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(viii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;To submit any amendment to the Plan for stockholder approval, including, but not limited to, amendments to the Plan intended to satisfy the requirements of (A) Section 422 of the Code regarding incentive stock options or (B) Rule 16b-3.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(ix)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;To approve forms of Stock Award Agreements for use under the Plan and to amend the terms of any one or more Stock Awards, including, but not limited to, amendments to provide terms more favorable to the Participant than previously provided in the Stock Award Agreement, subject to any specified limits in the Plan that are not subject to Board discretion&#59; </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">provided, however,</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> that a Participant&#8217;s rights under any Stock Award will not be impaired by any such amendment unless (A)&#160;the Company requests the consent of the affected Participant, and (B)&#160;such Participant consents in writing. Notwithstanding the foregoing, (1) a Participant&#8217;s rights will not be deemed to have been impaired by any such amendment if the Board, in its sole discretion, determines that the amendment, taken as a whole, does not </font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">materially impair the Participant&#8217;s rights, and (2) subject to the limitations of applicable law, if any, the Board may amend the terms of any one or more Stock Awards without the affected Participant&#8217;s consent (A)&#160;to maintain the qualified status of the Stock Award as an Incentive Stock Option under Section 422 of the Code&#59; (B) to change the terms of an Incentive Stock Option, if such change results in impairment of the Stock Award solely because it impairs the qualified status of the Stock Award as an Incentive Stock Option under Section 422 of the Code&#59; (C)&#160;to clarify the manner of exemption from, or to bring the Stock Award into compliance with, Section 409A of the Code&#59; or (D) to comply with other applicable laws or listing requirements.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(x)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;To appoint such agents as the Board may deem necessary or advisable to administer the Plan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(xi)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests of the Company and that are not in conflict with the provisions of the Plan or Stock Awards.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(xii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;To adopt such procedures and sub-plans as are necessary or appropriate to permit participation in the Plan by Employees, Directors or Consultants who are foreign nationals or employed outside the United States (provided that Board approval will not be necessary for immaterial modifications to the Plan or any Stock Award Agreement that are required for compliance with the laws of the relevant foreign jurisdiction).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(c)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8.46pt">Delegation to Committee</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(i)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">General.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The Board may delegate some or all of the administration of the Plan to a Committee or Committees. If administration of the Plan is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore possessed by the Board that have been delegated to the Committee, including the power to delegate to a subcommittee of the Committee any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be to the Committee or subcommittee, as applicable). Any delegation of administrative powers will be reflected in resolutions, not inconsistent with the provisions of the Plan, adopted from time to time by the Board or Committee (as applicable). The Committee may, at any time, abolish the subcommittee and&#47;or revest in the Committee any powers delegated to the subcommittee. The Board may retain the authority to concurrently administer the Plan with the Committee and may, at any time, revest in the Board some or all of the powers previously delegated.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(ii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Rule 16b-3 Compliance.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The Committee may consist solely of two or more Non-Employee Directors, in accordance with Rule 16b-3.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(d)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Delegation to an Officer. </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Board may delegate to one or more Officers the authority to do one or both of the following (i) designate Employees who are not Officers to be recipients of Options and SARs (and, to the extent permitted by applicable law, other Stock Awards) and, to the extent permitted by applicable law, the terms of such Stock Awards, and (ii) determine the number of shares of Common Stock to be subject to such Stock Awards granted to such Employees&#59; </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">provided, however</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, that the Board resolutions regarding such delegation will specify the total number of shares of Common Stock that may be subject to the Stock Awards granted by such Officer and that such Officer may not grant a Stock Award to himself or herself. Any such Stock Awards will be granted on the form of Stock Award Agreement most recently approved for use by the Committee or the Board, unless otherwise provided in the resolutions approving the delegation authority. The Board may not delegate authority to an Officer who is acting solely in the capacity of an Officer (and not also as a Director) to determine the Fair Market Value pursuant to Section 13(u)(iii) below.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(e)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Effect of Board&#8217;s Decision.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> All determinations, interpretations and constructions made by the Board in good faith will not be subject to review by any person and will be final, binding and conclusive on all persons.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(f)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:10.28pt">Repricing&#59; Cancellation and Re-Grant of Stock Awards.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Neither the Board nor any Committee will have the authority to (i) reduce the exercise, purchase or strike price of any outstanding Option or SAR under the Plan, or (ii) cancel any outstanding Option or SAR that has an exercise price or strike price greater than the then-current Fair Market Value of the Common Stock in exchange for cash or other Stock Awards under the Plan, unless the stockholders of the Company have approved such an action within 12 months prior to such an event.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(g)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Minimum Vesting Requirements. </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Except as provided in Section 9, no Stock Award will vest until at least twelve (12) months following the date of grant of such Stock Award&#59; </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">provided, however, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">that up to five percent (5%) of the Share Reserve (as defined in Section 3(a)) may be subject to Stock Awards that do not meet such vesting requirements.</font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(h)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Dividends and Dividend Equivalents. </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Dividends or dividend equivalents may be paid or credited, as applicable, with respect to any shares of Common Stock subject to a Stock Award (other than an Option or SAR), as determined by the Board and contained in the applicable Stock Award Agreement&#59; </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">provided, however</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, that (i) no dividends or dividend equivalents may be paid with respect to any such shares before the date such shares have vested under the terms of such Stock Award Agreement, (ii) any dividends or dividend equivalents that are credited with respect to any such shares will be subject to all of the terms and conditions applicable to such shares under the terms of such Stock Award Agreement (including, but not limited to, any vesting conditions), and (iii) any dividends or dividend equivalents that are credited with respect to any such shares will be forfeited to the Company on the date, if any, such shares are forfeited to or repurchased by the Company due to a failure to meet any vesting conditions under the terms of such Stock Award Agreement.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">3.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:11.16pt">Shares Subject to the Plan</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Share Reserve</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(i)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;Subject to Section 9(a) relating to Capitalization Adjustments, the aggregate number of shares of Common Stock that may be issued pursuant to Stock Awards from and after the Effective Date will not exceed (A) 25,384,114 shares (which number is the sum of (i) 1,800,000 shares originally approved by the Company&#8217;s stockholders in May 2018, (ii) 2,000,000 shares approved by the Company&#8217;s stockholders at the Company&#8217;s Annual Meeting of Stockholders in May 2019, (iii) 2,400,000 shares approved by the Company&#8217;s stockholders at the Company&#8217;s Annual Meeting of Stockholders in May 2020, (iv) 3,200,000 shares approved by the Company&#8217;s stockholders at the Company&#8217;s Annual Meeting of Stockholders in May 2021, (v) 2,000,000 shares approved by the Company&#8217;s stockholders at the Company&#8217;s Annual Meeting of Stockholders in May 2022, (vi) 2,700,000 shares approved by the Company&#8217;s stockholders at the Company&#8217;s Annual Meeting of Stockholders in May 2023, (vii) 2,700,000 shares approved by the Company&#8217;s stockholders at the Company&#8217;s Annual Meeting of Stockholders in May 2024, (viii) 4,000,000 shares approved by the Company&#8217;s stockholders at the Company&#8217;s Annual Meeting of Stockholders in May 2025, (ix) 3,000,000 shares approved by the Company&#8217;s stockholders at the Company&#8217;s Annual Meeting of Stockholders in May 2026, and (x) the number of shares (1,584,114) subject to the Prior Plans&#8217; Available Reserve, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">plus</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> (B) the Prior Plans&#8217; Returning Shares, if any, which become available for grant under this Plan from time to time (such aggregate number of shares described in (A) and (B) above, the &#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Share Reserve</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(ii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;For clarity, the Share Reserve in this Section 3(a) is a limitation on the number of shares of Common Stock that may be issued pursuant to the Plan. Accordingly, this Section 3(a) does not limit the granting of Stock Awards except as provided in Section 7(a). Shares may be issued in connection with a merger or acquisition as permitted by Nasdaq Listing Rule 5635(c) or, if applicable, NYSE Listed Company Manual Section 303A.08, AMEX Company Guide Section 711 or other applicable rule, and such issuance will not reduce the number of shares available for issuance under the Plan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(iii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;Subject to Section 3(b), the number of shares of Common Stock available for issuance under the Plan will be reduced by&#58; (A) one share for each share of Common Stock issued pursuant to an Option or SAR with respect to which the exercise or strike price is at least one hundred percent (100%) of the Fair Market Value of the Common Stock subject to the Option or SAR on the date of grant&#59; and (B) one share for each share of Common Stock issued pursuant to a Full Value Award.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Reversion of Shares to the Share Reserve</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(i)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Shares Available For Subsequent Issuance. </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">If (A) any shares of Common Stock subject to a Stock Award are not issued because such Stock Award or any portion thereof expires or otherwise terminates without all of the shares covered by such Stock Award having been issued or is settled in cash (</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">i.e.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, the Participant receives cash rather than stock), or (B) any shares of Common Stock issued pursuant to a Stock Award are forfeited back to or repurchased by the Company because of the failure to meet a contingency or condition required for the vesting of such shares, such shares will again become available for issuance under the Plan (collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">2018 Plan Returning Shares</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;). For each (1) 2018 Plan Returning Share subject to a Full Value Award or (2) Prior Plans&#8217; Returning Share subject to a stock award other than an option or stock appreciation right granted under the Prior Plan, with respect to which the exercise or strike price is at least one hundred percent (100%) of the Fair Market Value of the Common Stock subject to the option or stock appreciation right on the date of grant, the number of shares of Common Stock available for issuance under the Plan will increase by the share ratio used at time of grant.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(ii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Shares Not Available For Subsequent Issuance. </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Any shares of Common Stock reacquired or withheld (or not issued) by the Company to satisfy the exercise or purchase price of a Stock Award will no longer be available for issuance under the Plan, including any shares subject to a Stock Award that are not delivered to a Participant because such Stock Award is exercised through a reduction of shares </font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">subject to such Stock Award (</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">i.e</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">., &#8220;net exercised&#8221;). In addition, any shares reacquired or withheld (or not issued) by the Company to satisfy a tax withholding obligation in connection with a Stock Award or a stock award under a Prior Plan, or any shares repurchased by the Company on the open market with the proceeds of the exercise or strike price of an Option or Stock Appreciation Right or similar award under a Prior Plan will no longer be available for issuance under the Plan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(c)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8.46pt">Incentive Stock Option Limit. </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Subject to the Share Reserve and Section 9(a) relating to Capitalization Adjustments, the aggregate maximum number of shares of Common Stock that may be issued pursuant to the exercise of Incentive Stock Options will be 8,000,000.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(d)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Source of Shares.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The stock issuable under the Plan will be shares of authorized but unissued or reacquired Common Stock, including shares repurchased by the Company on the open market or otherwise.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(e)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Non-Employee Director Aggregate Compensation Limit.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The aggregate value of all compensation granted or paid, as applicable, to any individual for service as a Non-Employee Director with respect to any period commencing on the date of the Company&#8217;s Annual Meeting of Stockholders for a particular year and ending on the day immediately prior to the date of the Company&#8217;s Annual Meeting of Stockholders for the next subsequent year, including Awards granted and cash fees paid by the Company to such Non-Employee Director, will not exceed (i) $750,000 in total value or (ii) in the event such Non-Employee Director is first appointed or elected to the Board during such period, $1,250,000 in total value, in each case calculating the value of any Awards based on the grant date fair value of such Awards for financial reporting purposes.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">4.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:11.16pt">Eligibility</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Eligibility for Specific Stock Awards.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Incentive Stock Options may be granted only to employees of the Company or a &#8220;parent corporation&#8221; or &#8220;subsidiary corporation&#8221; thereof (as such terms are defined in Sections 424(e) and 424(f) of the Code). Stock Awards other than Incentive Stock Options may be granted to Employees, Directors and Consultants&#59; provided, however, that Stock Awards may not be granted to Employees, Directors and Consultants who are providing Continuous Service only to any &#8220;parent&#8221; of the Company, as such term is defined in Rule 405, unless (i) the stock underlying such Stock Awards is treated as &#8220;service recipient stock&#8221; under Section 409A of the Code (for example, because the Stock Awards are granted pursuant to a corporate transaction such as a spin off transaction) or (ii) the Company, in consultation with its legal counsel, has determined that such Stock Awards are otherwise exempt from or alternatively comply with the distribution requirements of Section 409A of the Code.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Ten Percent Stockholders.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> A Ten Percent Stockholder will not be granted an Incentive Stock Option unless the exercise price of such Option is at least one hundred ten percent (110%) of the Fair Market Value on the date of grant and the Option is not exercisable after the expiration of five (5) years from the date of grant.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">5.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:11.16pt">Provisions Relating to Options and Stock Appreciation Rights</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Each Option or SAR will be in such form and will contain such terms and conditions as the Board deems appropriate. All Options will be separately designated Incentive Stock Options or Nonstatutory Stock Options at the time of grant, and, if certificates are issued, a separate certificate or certificates will be issued for shares of Common Stock purchased on exercise of each type of Option. If an Option is not specifically designated as an Incentive Stock Option, or if an Option is designated as an Incentive Stock Option but some portion or all of the Option fails to qualify as an Incentive Stock Option under the applicable rules, then the Option (or portion thereof) will be a Nonstatutory Stock Option. The provisions of separate Options or SARs need not be identical&#59; </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">provided, however</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, that each Stock Award Agreement will conform to (through incorporation of provisions hereof by reference in the applicable Stock Award Agreement or otherwise) the substance of each of the following provisions&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Term.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Subject to the provisions of Section 4(b) regarding Ten Percent Stockholders, no Option or SAR will be exercisable after the expiration of ten (10) years from the date of its grant or such shorter period specified in the Stock Award Agreement.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Exercise Price.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Subject to the provisions of Section 4(b) regarding Ten Percent Stockholders, the exercise or strike price of each Option or SAR will be not less than one hundred percent (100%) of the Fair Market Value of the Common Stock subject to the Option or SAR on the date the Stock Award is granted. Notwithstanding the foregoing, an Option or SAR may be granted with an exercise or strike price lower than one hundred percent (100%) of the Fair Market Value of the Common Stock subject to the Stock Award if such Stock Award is granted pursuant to an assumption of or substitution for another option or stock appreciation right pursuant to a Corporate Transaction and in </font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">a manner consistent with the provisions of Section 409A of the Code and, if applicable, Section 424(a) of the Code. Each SAR will be denominated in shares of Common Stock equivalents.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(c)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8.46pt">Purchase Price for Options.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The purchase price of Common Stock acquired pursuant to the exercise of an Option may be paid, to the extent permitted by applicable law and as determined by the Board in its sole discretion, by any combination of the methods of payment set forth below. The Board will have the authority to grant Options that do not permit all of the following methods of payment (or that otherwise restrict the ability to use certain methods) and to grant Options that require the consent of the Company to use a particular method of payment. The permitted methods of payment are as follows&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(i)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;by cash, check, bank draft or money order payable to the Company&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(ii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board that, prior to the issuance of the Common Stock subject to the Option, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions to pay the aggregate exercise price to the Company from the sales proceeds&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(iii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;by delivery to the Company (either by actual delivery or attestation) of shares of Common Stock&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(iv)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;if an Option is a Nonstatutory Stock Option, by a &#8220;net exercise&#8221; arrangement pursuant to which the Company will reduce the number of shares of Common Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value that does not exceed the aggregate exercise price&#59; </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">provided, however</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, that the Company will accept a cash or other payment from the Participant to the extent of any remaining balance of the aggregate exercise price not satisfied by such reduction in the number of whole shares to be issued. Shares of Common Stock will no longer be subject to an Option and will not be exercisable thereafter to the extent that (A) shares issuable upon exercise are used to pay the exercise price pursuant to the &#8220;net exercise,&#8221; (B) shares are delivered to the Participant as a result of such exercise, and (C) shares are withheld to satisfy tax withholding obligations&#59; or</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(v)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;in any other form of legal consideration that may be acceptable to the Board and specified in the applicable Stock Award Agreement.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(d)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Exercise and Payment of a SAR.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> To exercise any outstanding SAR, the Participant must provide written notice of exercise to the Company in compliance with the provisions of the Stock Award Agreement evidencing such SAR. The appreciation distribution payable on the exercise of a SAR will be not greater than an amount equal to the excess of (A)&#160;the aggregate Fair Market Value (on the date of the exercise of the SAR) of a number of shares of Common Stock equal to the number of Common Stock equivalents in which the Participant is vested under such SAR, and with respect to which the Participant is exercising the SAR on such date, over (B) the aggregate strike price of the number of Common Stock equivalents with respect to which the Participant is exercising the SAR on such date. The appreciation distribution may be paid in Common Stock, in cash, in any combination of the two or in any other form of consideration, as determined by the Board and contained in the Stock Award Agreement evidencing such SAR.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(e)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Transferability of Options and SARs.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The Board may, in its sole discretion, impose such limitations on the transferability of Options and SARs as the Board will determine. In the absence of such a determination by the Board to the contrary, the restrictions set forth in this Section 5(e) on the transferability of Options and SARs will apply. Notwithstanding the foregoing or anything in the Plan or a Stock Award Agreement to the contrary, no Option or SAR may be transferred to any financial institution without prior stockholder approval.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(i)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Restrictions on Transfer.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> An Option or SAR will not be transferable except by will or by the laws of descent and distribution (and pursuant to Sections 5(e)(ii) and 5(e)(iii) below) and will be exercisable during the lifetime of the Participant only by the Participant. Subject to the foregoing paragraph, the Board may permit transfer of the Option or SAR in a manner that is not prohibited by applicable tax and securities laws. Except as explicitly provided in the Plan, neither an Option nor a SAR may be transferred for consideration.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(ii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Domestic Relations Orders.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Subject to the approval of the Board or a duly authorized Officer, an Option or SAR may be transferred pursuant to the terms of a domestic relations order, official marital settlement agreement or other divorce or separation instrument as permitted by Treasury Regulations Section 1.421-1(b)(2). If an Option is an Incentive Stock Option, such Option may be deemed to be a Nonstatutory Stock Option as a result of such transfer.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(iii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Beneficiary Designation.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Subject to the approval of the Board or a duly authorized Officer, a Participant may, by delivering written notice to the Company, in a form approved by the Company (or the designated broker), designate a third party who, upon the death of the Participant, will thereafter be entitled to exercise the Option or SAR and receive the Common Stock or other consideration resulting from such exercise. In the absence of such a designation, upon the death of the Participant, the executor or administrator of the Participant&#8217;s </font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">estate will be entitled to exercise the Option or SAR and receive the Common Stock or other consideration resulting from such exercise. However, the Company may prohibit designation of a beneficiary at any time, including due to any conclusion by the Company that such designation would be inconsistent with the provisions of applicable laws.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(f)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:10.28pt">Vesting Generally.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The total number of shares of Common Stock subject to an Option or SAR may vest and become exercisable in periodic installments that may or may not be equal. The Option or SAR may be subject to such other terms and conditions on the time or times when it may or may not be exercised (which may be based on the satisfaction of Performance Goals or other criteria) as the Board may deem appropriate. The vesting provisions of individual Options or SARs may vary. The provisions of this Section 5(f) are subject to Section 2(g) and to any Option or SAR provisions governing the minimum number of shares of Common Stock as to which an Option or SAR may be exercised.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(g)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Termination of Continuous Service.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Except as otherwise provided in the applicable Stock Award Agreement or other agreement between the Participant and the Company or an Affiliate, if a Participant&#8217;s Continuous Service terminates (other than for Cause and other than upon the Participant&#8217;s death or Disability), the Participant may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such Option or SAR as of the date of termination of Continuous Service), but only within such period of time ending on the earlier of (i) the date three (3) months following the termination of the Participant&#8217;s Continuous Service (or such longer or shorter period specified in the applicable Stock Award Agreement), and (ii) the expiration of the term of the Option or SAR as set forth in the Stock Award Agreement. If, after termination of Continuous Service, the Participant does not exercise his or her Option or SAR (as applicable) within the applicable time frame, the Option or SAR (as applicable) will terminate.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(h)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Extension of Termination Date.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Except as otherwise provided in the applicable Stock Award Agreement or other agreement between the Participant and the Company or an Affiliate,</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">if the exercise of an Option or SAR following the termination of the Participant&#8217;s Continuous Service (other than for Cause and other than upon the Participant&#8217;s death or Disability) would be prohibited at any time solely because the issuance of shares of Common Stock would violate the registration requirements under the Securities Act, then the Option or SAR will terminate on the earlier of (i) the expiration of a total period of time (that need not be consecutive) equal to the applicable post-termination exercise period after the termination of the Participant&#8217;s Continuous Service during which the exercise of the Option or SAR would not be in violation of such registration requirements, or (ii) the expiration of the term of the Option or SAR as set forth in the applicable Stock Award Agreement. In addition, unless otherwise provided in a Participant&#8217;s Stock Award Agreement, if the sale of any Common Stock received upon exercise of an Option or SAR following the termination of the Participant&#8217;s Continuous Service (other than for Cause) would violate the Company&#8217;s insider trading policy, then the Option or SAR will terminate on the earlier of (i) the expiration of a period of time (that need not be consecutive) equal to the applicable post-termination exercise period after the termination of the Participant&#8217;s Continuous Service during which the sale of the Common Stock received upon exercise of the Option or SAR would not be in violation of the Company&#8217;s insider trading policy, or (ii) the expiration of the term of the Option or SAR as set forth in the applicable Stock Award Agreement.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(i)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:10.74pt">Disability of Participant.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Except as otherwise provided in the applicable Stock Award Agreement or other agreement between the Participant and the Company or an Affiliate, if a Participant&#8217;s Continuous Service terminates as a result of the Participant&#8217;s Disability, the Participant may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such Option or SAR as of the date of termination of Continuous Service), but only within such period of time ending on the earlier of (i) the date 12 months following such termination of Continuous Service (or such longer or shorter period specified in the Stock Award Agreement), and (ii)&#160;the expiration of the term of the Option or SAR as set forth in the Stock Award Agreement. If, after termination of Continuous Service, the Participant does not exercise his or her Option or SAR (as applicable) within the applicable time frame, the Option or SAR (as applicable) will terminate.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(j)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:10.74pt">Death of Participant.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Except as otherwise provided in the applicable Stock Award Agreement or other agreement between the Participant and the Company or an Affiliate, if (i) a Participant&#8217;s Continuous Service terminates as a result of the Participant&#8217;s death, or (ii) the Participant dies within the period (if any) specified in the Stock Award Agreement for exercisability after the termination of the Participant&#8217;s Continuous Service (for a reason other than death), then the Participant&#8217;s Option or SAR may be exercised (to the extent that the Participant was entitled to exercise such Option or SAR as of the date of death) by the Participant&#8217;s estate, by a person who acquired the right to exercise the Option or SAR by bequest or inheritance or by a person designated to exercise the Option or SAR upon the Participant&#8217;s death, but only within such period of time ending on the earlier of (i) the date 18 months following the date of death (or such longer or shorter period specified in the Stock Award Agreement), and (ii) the expiration of the term of such Option or SAR as set forth in the Stock Award Agreement. If, after the Participant&#8217;s death, the Option or SAR (as applicable) is not exercised within the applicable time frame, the Option or SAR (as applicable) will terminate.</font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(k)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8.46pt">Termination for Cause.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Except as explicitly provided otherwise in a Participant&#8217;s Stock Award Agreement or other individual written agreement between the Company or an Affiliate and the Participant, if a Participant&#8217;s Continuous Service is terminated for Cause, the Participant&#8217;s Option or SAR will terminate immediately upon such Participant&#8217;s termination of Continuous Service and be forfeited, and the Participant will be prohibited from exercising his or her Option or SAR from and after the time of such termination of Continuous Service.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(l)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:10.74pt">Non-Exempt Employees.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> If an Option or SAR is granted to an Employee who is a non-exempt employee for purposes of the Fair Labor Standards Act of 1938, as amended, the Option or SAR will not be first exercisable for any shares of Common Stock until at least six months following the date of grant of the Option or SAR (although the Stock Award may vest prior to such date). Consistent with the provisions of the Worker Economic Opportunity Act, (i) if such non-exempt employee dies or suffers a Disability, (ii) upon a Corporate Transaction in which such Option or SAR is not assumed, continued, or substituted, (iii) upon a Change in Control, or (iv) upon the Participant&#8217;s retirement (as such term may be defined in the Participant&#8217;s Stock Award Agreement, in another agreement between the Participant and the Company or an Affiliate, or, if no such definition, in accordance with the Company&#8217;s or Affiliate&#8217;s then current employment policies and guidelines), the vested portion of any Options and SARs may be exercised earlier than six&#160;months following the date of grant. The foregoing provision is intended to operate so that any income derived by a non-exempt employee in connection with the exercise or vesting of an Option or SAR will be exempt from the employee&#8217;s regular rate of pay. To the extent permitted and&#47;or required for compliance with the Worker Economic Opportunity Act to ensure that any income derived by a non-exempt employee in connection with the exercise, vesting or issuance of any shares under any other Stock Award will be exempt from the employee&#8217;s regular rate of pay, the provisions of this Section 5(l) will apply to all Stock Awards and are hereby incorporated by reference into such Stock Award Agreements.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">6.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:11.16pt">Provisions of Stock Awards Other than Options and SARs</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Restricted Stock Awards.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Each Restricted Stock Award Agreement will be in such form and will contain such terms and conditions as the Board deems appropriate. To the extent consistent with the Company&#8217;s bylaws, at the Board&#8217;s election, shares of Common Stock underlying a Restricted Stock Award may be (i) held in book entry form subject to the Company&#8217;s instructions until any restrictions relating to the Restricted Stock Award lapse, or (ii)&#160;evidenced by a certificate, which certificate will be held in such form and manner as determined by the Board. The terms and conditions of Restricted Stock Award Agreements may change from time to time, and the terms and conditions of separate Restricted Stock Award Agreements need not be identical. Each Restricted Stock Award Agreement will conform to (through incorporation of the provisions hereof by reference in the agreement or otherwise) the substance of each of the following provisions&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(i)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Consideration.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> A Restricted Stock Award may be awarded in consideration for (A) cash, check, bank draft or money order payable to the Company, (B) past services to the Company or an Affiliate, or (C) any other form of legal consideration (including future services) that may be acceptable to the Board, in its sole discretion, and permissible under applicable law.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(ii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Vesting. </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Subject to Section 2(g), shares of Common Stock awarded under the Restricted Stock Award Agreement may be subject to forfeiture to the Company in accordance with a vesting schedule to be determined by the Board.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(iii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Termination of Participant&#8217;s Continuous Service.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> If a Participant&#8217;s Continuous Service terminates, the Company may receive through a forfeiture condition or a repurchase right any or all of the shares of Common Stock held by the Participant as of the date of termination of Continuous Service under the terms of the Restricted Stock Award Agreement.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(iv)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Transferability.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Rights to acquire shares of Common Stock under the Restricted Stock Award Agreement will be transferable by the Participant only upon such terms and conditions as are set forth in the Restricted Stock Award Agreement, as the Board will determine in its sole discretion, so long as Common Stock awarded under the Restricted Stock Award Agreement remains subject to the terms of the Restricted Stock Award Agreement. Notwithstanding the foregoing or anything in the Plan or a Restricted Stock Award Agreement to the contrary, no Restricted Stock Award may be transferred to any financial institution without prior stockholder approval.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Restricted Stock Unit Awards. </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Each Restricted Stock Unit Award Agreement will be in such form and will contain such terms and conditions as the Board deems appropriate. The terms and conditions of Restricted Stock Unit Award Agreements may change from time to time, and the terms and conditions of separate Restricted Stock Unit Award Agreements need not be identical. Each Restricted Stock Unit Award Agreement will conform to (through incorporation of the provisions hereof by reference in the Agreement or otherwise) the substance of each of the following provisions&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(i)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Consideration.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> At the time of grant of a Restricted Stock Unit Award, the Board will determine the consideration, if any, to be paid by the Participant upon delivery of each share of Common Stock subject to the Restricted Stock Unit Award. The consideration to be </font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">paid (if any) by the Participant for each share of Common Stock subject to a Restricted Stock Unit Award may be paid in any form of legal consideration that may be acceptable to the Board, in its sole discretion, and permissible under applicable law.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(ii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Vesting. </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Subject to Section 2(g), at the time of the grant of a Restricted Stock Unit Award, the Board may impose such restrictions on or conditions to the vesting of the Restricted Stock Unit Award as it, in its sole discretion, deems appropriate.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(iii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Payment.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> A Restricted Stock Unit Award may be settled by the delivery of shares of Common Stock, their cash equivalent, any combination thereof or in any other form of consideration, as determined by the Board and contained in the Restricted Stock Unit Award Agreement.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(iv)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Additional Restrictions. </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">At the time of the grant of a Restricted Stock Unit Award, the Board, as it deems appropriate, may impose such restrictions or conditions that delay the delivery of the shares of Common Stock (or their cash equivalent) subject to a Restricted Stock Unit Award to a time after the vesting of such Restricted Stock Unit Award.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(v)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Termination of Participant&#8217;s Continuous Service. </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Except as otherwise provided in the applicable Restricted Stock Unit Award Agreement, such portion of the Restricted Stock Unit Award that has not vested will be forfeited upon the Participant&#8217;s termination of Continuous Service.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(c)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8.46pt">Performance Stock Awards</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(i)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Performance Stock Awards.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> A Performance Stock Award is a Stock Award that is payable (including that may be granted, vest or be exercised) contingent upon the attainment during a Performance Period of certain Performance Goals. A Performance Stock Award may, but need not, require the Participant&#8217;s completion of a specified period of Continuous Service. Subject to Section 2(g), the length of any Performance Period, the Performance Goals to be achieved during the Performance Period, and the measure of whether and to what degree such Performance Goals have been attained will be conclusively determined by the Board, in its sole discretion. In addition, to the extent permitted by applicable law and the applicable Stock Award Agreement, the Board may determine that cash may be used in payment of Performance Stock Awards.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(ii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Discretion.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The Board retains the discretion to reduce or eliminate the compensation or economic benefit due upon the attainment of any Performance Goals and to define the manner of calculating the Performance Criteria it selects to use for a Performance Period.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(d)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Other Stock Awards. </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Other forms of Stock Awards valued in whole or in part by reference to, or otherwise based on, Common Stock, including the appreciation in value thereof (</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">e.g</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">., options or stock appreciation rights with an exercise price or strike price less than one hundred percent (100%) of the Fair Market Value of the Common Stock at the time of grant) may be granted either alone or in addition to Stock Awards granted under Section 5 and this Section 6. Subject to the provisions of the Plan (including, but not limited to, Sections 2(g) and 2(h)), the Board will have sole and complete authority to determine the persons to whom and the time or times at which such Other Stock Awards will be granted, the number of shares of Common Stock (or the cash equivalent thereof) to be granted pursuant to such Other Stock Awards and all other terms and conditions of such Other Stock Awards.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">7.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:11.16pt">Covenants of the Company</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Availability of Shares.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The Company will keep available at all times the number of shares of Common Stock reasonably required to satisfy then-outstanding Stock Awards.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Securities Law Compliance.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The Company will seek to obtain from each regulatory commission or agency having jurisdiction over the Plan the authority required to grant Stock Awards and to issue and sell shares of Common Stock upon exercise of the Stock Awards&#59; </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">provided, however</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, that this undertaking will not require the Company to register under the Securities Act the Plan, any Stock Award or any Common Stock issued or issuable pursuant to any such Stock Award. If, after reasonable efforts and at a reasonable cost, the Company is unable to obtain from any such regulatory commission or agency the authority that counsel for the Company deems necessary for the lawful issuance and sale of Common Stock under the Plan, the Company will be relieved from any liability for failure to issue and sell Common Stock upon exercise of such Stock Awards unless and until such authority is obtained. A Participant will not be eligible for the grant of a Stock Award or the subsequent issuance of cash or Common Stock pursuant to the Stock Award if such grant or issuance would be in violation of any applicable securities law.</font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(c)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8.46pt">No Obligation to Notify or Minimize Taxes. </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Company will have no duty or obligation to any Participant to advise such holder as to the time or manner of exercising a Stock Award. Furthermore, the Company will have no duty or obligation to warn or otherwise advise such holder of a pending termination or expiration of a Stock Award or a possible period in which the Stock Award may not be exercised. The Company has no duty or obligation to minimize the tax consequences of a Stock Award to the holder of such Stock Award.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">8.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:11.16pt">Miscellaneous</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Use of Proceeds from Sales of Common Stock. </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Proceeds from the sale of shares of Common Stock issued pursuant to Stock Awards will constitute general funds of the Company.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Corporate Action Constituting Grant of Stock Awards.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Corporate action constituting a grant by the Company of a Stock Award to any Participant will be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument, certificate, or letter evidencing the Stock Award is communicated to, or actually received or accepted by, the Participant. In the event that the corporate records (</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">e.g</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">., Board consents, resolutions or minutes) documenting the corporate action constituting the grant contain terms (</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">e.g</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">., exercise price, vesting schedule or number of shares) that are inconsistent with those in the Stock Award Agreement or related grant documents as a result of a clerical error in the preparation of the Stock Award Agreement or related grant documents, the corporate records will control and the Participant will have no legally binding right to the incorrect terms in the Stock Award Agreement or related grant documents.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(c)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8.46pt">Stockholder Rights.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> No Participant will be deemed to be the holder of, or to have any of the rights of a holder with respect to, any shares of Common Stock subject to a Stock Award unless and until (i) such Participant has satisfied all requirements for exercise of, or the issuance of shares of Common Stock under, the Stock Award pursuant to its terms, and (ii) the issuance of the Common Stock subject to such Stock Award has been entered into the books and records of the Company.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(d)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">No Employment or Other Service Rights. </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Nothing in the Plan, any Stock Award Agreement or any other instrument executed thereunder or in connection with any Stock Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company or an Affiliate in the capacity in effect at the time the Stock Award was granted or will affect the right of the Company or an Affiliate to terminate (i) the employment of an Employee with or without notice and with or without cause, (ii) the service of a Consultant pursuant to the terms of such Consultant&#8217;s agreement with the Company or an Affiliate, or (iii) the service of a Director pursuant to the bylaws of the Company or an Affiliate, and any applicable provisions of the corporate law of the state in which the Company or the Affiliate is incorporated, as the case may be.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(e)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Change in Time Commitment.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> In the event a Participant&#8217;s regular level of time commitment in the performance of his or her services for the Company or any Affiliate is reduced (for example, and without limitation, if the Participant is an Employee of the Company and the Employee has a change in status from a full-time Employee to a part-time Employee) after the date of grant of any Stock Award to the Participant, the Board has the right in its sole discretion to (x) make a corresponding reduction in the number of shares or cash amount subject to any portion of such Stock Award that is scheduled to vest or become payable after the date of such change in time commitment, and (y) in lieu of or in combination with such a reduction, extend the vesting or payment schedule applicable to such Stock Award. In the event of any such reduction, the Participant will have no right with respect to any portion of the Stock Award that is so reduced or extended.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(f)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:10.28pt">Incentive Stock Option Limitations.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> To the extent that the aggregate Fair Market Value (determined at the time of grant) of Common Stock with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar year (under all plans of the Company and any Affiliates) exceeds $100,000 (or such other limit established in the Code) or otherwise does not comply with the rules governing Incentive Stock Options, the Options or portions thereof that exceed such limit (according to the order in which they were granted) or otherwise do not comply with such rules will be treated as Nonstatutory Stock Options, notwithstanding any contrary provision of the applicable Option Agreement(s).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(g)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Investment Assurances.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The Company may require a Participant, as a condition of exercising or acquiring Common Stock under any Stock Award, (i) to give written assurances satisfactory to the Company as to the Participant&#8217;s knowledge and experience in financial and business matters and&#47;or to employ a purchaser representative reasonably satisfactory to the Company who is knowledgeable and experienced in financial and business matters and that the Participant is capable of evaluating, alone or together with the purchaser representative, the merits and risks of exercising the Stock Award&#59; and (ii) to give written assurances satisfactory to the Company stating that the Participant is acquiring Common Stock subject to the Stock Award for the Participant&#8217;s own account and not with any present intention of selling or otherwise distributing the Common Stock. The foregoing requirements, and any assurances given pursuant to such requirements, </font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">will be inoperative if (A) the issuance of the shares upon the exercise or acquisition of Common Stock under the Stock Award has been registered under a then currently effective registration statement under the Securities Act, or (B) as to any particular requirement, a determination is made by counsel for the Company that such requirement need not be met in the circumstances under the then applicable securities laws. The Company may, upon advice of counsel to the Company, place legends on stock certificates issued under the Plan as such counsel deems necessary or appropriate in order to comply with applicable securities laws, including, but not limited to, legends restricting the transfer of the Common Stock.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(h)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Withholding Obligations. </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Unless prohibited by the terms of a Stock Award Agreement, the Company may, in its sole discretion, satisfy any federal, state or local tax withholding obligation relating to a Stock Award by any of the following means or by a combination of such means&#58; (i) causing the Participant to tender a cash payment&#59; (ii) withholding shares of Common Stock from the shares of Common Stock issued or otherwise issuable to the Participant in connection with the Stock Award&#59; </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">provided, however, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">that no shares of Common Stock are withheld with a value exceeding the maximum amount of tax that may be required to be withheld by law (or such other amount as may be permitted while still avoiding classification of the Stock Award as a liability for financial accounting purposes)&#59; (iii) withholding cash from a Stock Award settled in cash&#59; (iv) withholding payment from any amounts otherwise payable to the Participant&#59; or (v) by such other method as may be set forth in the Stock Award Agreement.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(i)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:10.74pt">Electronic Delivery.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Any reference herein or in a Stock Award Agreement to a &#8220;written&#8221; agreement or document will include any agreement or document delivered electronically, filed publicly at www.sec.gov (or any successor website thereto) or posted on the Company&#8217;s intranet (or other shared electronic medium controlled by the Company to which the Participant has access). By accepting any Stock Award, the Participant consents to receive documents by electronic delivery and to participate in the Plan through any on-line electronic system established and maintained by the Board or another third party selected by the Board. The form of delivery of any Common Stock (e.g., a stock certificate or electronic entry evidencing such shares) shall be determined by the Company.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(j)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:10.74pt">Deferrals.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> To the extent permitted by applicable law, the Board, in its sole discretion, may determine that the delivery of Common Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Stock Award may be deferred and may establish programs and procedures for deferral elections to be made by Participants. Deferrals by Participants will be made in accordance with Section 409A of the Code. Consistent with Section 409A of the Code, the Board may provide for distributions while a Participant is still an employee or otherwise providing services to the Company or an Affiliate. The Board is authorized to make deferrals of Stock Awards and determine when, and in what annual percentages, Participants may receive payments, including lump sum payments, following the Participant&#8217;s termination of Continuous Service, and implement such other terms and conditions consistent with the provisions of the Plan and in accordance with applicable law.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(k)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8.46pt">Compliance with Section 409A of the Code. </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Unless otherwise expressly provided for in a Stock Award Agreement, the Plan and Stock Award Agreements will be interpreted to the greatest extent possible in a manner that makes the Plan and the Stock Awards granted hereunder exempt from Section 409A of the Code, and, to the extent not so exempt, in compliance with Section 409A of the Code. To the extent that the Board determines that any Stock Award granted hereunder is not exempt from and is therefore subject to Section 409A of the Code, the Stock Award Agreement evidencing such Stock Award will incorporate the terms and conditions necessary to avoid the consequences specified in Section 409A(a)(1) of the Code, and, to the extent applicable, the Plan and Stock Award Agreements will be interpreted in accordance with the requirements of Section 409A of the Code. Notwithstanding anything to the contrary in this Plan (and unless the Stock Award Agreement specifically provides otherwise), if the shares of Common Stock are publicly traded and a Participant holding a Stock Award that constitutes &#8220;deferred compensation&#8221; under Section 409A of the Code is a &#8220;specified employee&#8221; for purposes of Section 409A of the Code, no distribution or payment of any amount will be made upon a &#8220;separation from service&#8221; before a date that is six&#160;months following the date of such Participant&#8217;s &#8220;separation from service&#8221; (as defined in Section 409A of the Code without regard to alternative definitions thereunder) or, if earlier, the date of the Participant&#8217;s death.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(l)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:10.74pt">Clawback&#47;Recovery.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> All Stock Awards granted under the Plan will be subject to recoupment in accordance with any clawback policy that the Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company&#8217;s securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable law. In addition, the Board may impose such other clawback, recovery or recoupment provisions in a Stock Award Agreement as the Board determines necessary or appropriate, including but not limited to a reacquisition right in respect of previously acquired shares of Common Stock or other cash or property upon the occurrence of an event constituting Cause. No recovery of compensation under such a </font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">clawback policy will be an event giving rise to a right to resign for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or similar term) under any agreement with the Company or an Affiliate.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">9.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:11.16pt">Adjustments upon Changes in Common Stock&#59; Other Corporate Events</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Capitalization Adjustments. </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">In the event of a Capitalization Adjustment, the Board will appropriately and proportionately adjust&#58; (i) the class(es) and maximum number of securities subject to the Plan pursuant to Section 3(a), (ii) the class(es) and maximum number of securities that may be issued pursuant to the exercise of Incentive Stock Options pursuant to Section 3(c), and (iii) the class(es) and number of securities and price per share of stock subject to outstanding Stock Awards. The Board will make such adjustments, and its determination will be final, binding and conclusive.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Dissolution.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> Except as otherwise provided in the Stock Award Agreement, in the event of a Dissolution of the Company, all outstanding Stock Awards (other than Stock Awards consisting of vested and outstanding shares of Common Stock not subject to a forfeiture condition or the Company&#8217;s right of repurchase) will terminate immediately prior to the completion of such Dissolution, and the shares of Common Stock subject to the Company&#8217;s repurchase rights or subject to a forfeiture condition may be repurchased or reacquired by the Company notwithstanding the fact that the holder of such Stock Award is providing Continuous Service, </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">provided, however</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, that the Board may, in its sole discretion, cause some or all Stock Awards to become fully vested, exercisable and&#47;or no longer subject to repurchase or forfeiture (to the extent such Stock Awards have not previously expired or terminated) before the Dissolution is completed but contingent on its completion.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(c)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8.46pt">Transactions. </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The following provisions will apply to Stock Awards in the event of a Transaction. In the event of a Transaction, then, notwithstanding any other provision of the Plan, the Board may take one or more of the following actions with respect to Stock Awards, contingent upon the closing or completion of the Transaction, and </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">provided that</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> the Board may take the actions described in Sections 9(c)(iii) through 9(c)(vi) only if the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company) does not consent to the actions in Sections 9(c)(i) and 9(c)(ii)&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(i)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;arrange for the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company) to assume or continue the Stock Award or to substitute a similar stock award for the Stock Award (including, but not limited to, an award to acquire the same consideration paid to the stockholders of the Company pursuant to the Transaction)&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(ii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;arrange for the assignment of any reacquisition or repurchase rights held by the Company in respect of Common Stock issued pursuant to the Stock Award to the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company)&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(iii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;accelerate the vesting, in whole or in part, of the Stock Award (and, if applicable, the time at which the Stock Award may be exercised) to a date prior to the effective time of such Transaction as the Board determines (or, if the Board does not determine such a date, to the date that is five (5) days prior to the effective date of the Transaction), with such Stock Award terminating if not exercised (if applicable) at or prior to the effective time of the Transaction&#59; </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">provided, however</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, that the Board may require Participants to complete and deliver to the Company a notice of exercise before the effective date of a Transaction, which exercise is contingent upon the effectiveness of such Transaction&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(iv)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by the Company with respect to the Stock Award&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(v)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;cancel or arrange for the cancellation of the Stock Award, to the extent not vested or not exercised prior to the effective time of the Transaction, in exchange for such cash consideration or no consideration as the Board, in its sole discretion, may consider appropriate&#59; and</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(vi)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;make a payment, in such form as may be determined by the Board equal to the excess, if any, of (A) the value of the property the Participant would have received upon the exercise of the Stock Award immediately prior to the effective time of the Transaction, over (B) any exercise price payable by such holder in connection with such exercise.</font><font style="color:#0000ff;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">For clarity, this payment may be zero ($0) if the value of the property is equal to or less than the exercise price. Payments under this provision may be delayed to the same extent that payment of consideration to the holders of the Company&#8217;s Common Stock in connection with the Transaction is delayed as a result of escrows, earn outs, holdbacks or any other contingencies.</font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The Board need not take the same action or actions with respect to all Stock Awards or portions thereof or with respect to all Participants. The Board may take different actions with respect to the vested and unvested portions of a Stock Award.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(d)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">Appointment of Stockholder Representative.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> As a condition to the receipt of a Stock Award under this Plan, a Participant will be deemed to have agreed that the Stock Award will be subject to the terms of any provision in the agreement governing a Transaction involving the Company for the appointment of a stockholder representative that is authorized to act on the Participant&#8217;s behalf with respect to any escrow, indemnities and any contingent consideration. </font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(e)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">No Restriction on Right to Undertake Transactions.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> The grant of any Stock Award under the Plan and the issuance of shares pursuant to any Stock Award does not affect or restrict in any way the right or power of the Company or the stockholders of the Company to make or authorize any adjustment, recapitalization, reorganization or other change in the Company&#8217;s capital structure or its business, any merger or consolidation of the Company, any issue of stock or of options, rights or options to purchase stock or of bonds, debentures, preferred or prior preference stocks whose rights are superior to or affect the Common Stock or the rights thereof or which are convertible into or exchangeable for Common Stock, or the dissolution or liquidation of the Company, or any sale or transfer of all or any part of its assets or business, or any other corporate act or proceeding, whether of a similar character or otherwise.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(f)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:10.28pt">Change in Control. </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">A Stock Award may be subject to additional acceleration of vesting and exercisability upon or after a termination of Continuous Service in connection with a Change in Control as may be provided in the Stock Award Agreement for such Stock Award or as may be provided in any other written agreement between the Company or any Affiliate and the Participant, but in the absence of such provision, no such acceleration will occur.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">10.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:6.6pt">Plan Term&#59; Earlier Termination or Suspension of the Plan</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:8pt">The Board may suspend or terminate the Plan at any time. No Incentive Stock Option will be granted after</font><font style="color:#0070c0;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">the tenth (10</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:6.5pt;font-weight:400;line-height:139%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">) anniversary of the earlier of (i) the date the Plan is adopted by the Board, or (ii) the date the Plan is approved by the stockholders of the Company. No Stock Awards may be granted under the Plan while the Plan is suspended or after it is terminated.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">No Impairment of Rights. </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Suspension or termination of the Plan will not materially impair rights and obligations under any Stock Award granted while the Plan is in effect except with the written consent of the affected Participant or as otherwise permitted in the Plan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">11.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:6.6pt">Effective Date of Plan</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">This Plan will become effective on the Effective Date.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">12.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:6.6pt">Choice of Law</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">The laws of the State of Delaware will govern all questions concerning the construction, validity and interpretation of this Plan, without regard to that state&#8217;s conflict of laws rules.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">13.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:6.6pt">Definitions. </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">As used in the Plan, the following definitions will apply to the capitalized terms indicated below&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(a)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:8pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Affiliate</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means, at the time of determination, any &#8220;parent&#8221; or &#8220;subsidiary&#8221; of the Company as such terms are defined in Rule 405. The Board will have the authority to determine the time or times at which &#8220;parent&#8221; or &#8220;subsidiary&#8221; status is determined within the foregoing definition.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(b)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:8pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Board</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means the Board of Directors of the Company.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(c)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:8.46pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Capitalization Adjustment</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means any change that is made in, or other events that occur with respect to, the Common Stock subject to the Plan or subject to any Stock Award after the Effective Date without the receipt of consideration by the Company through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, large nonrecurring cash dividend, stock split, reverse stock split, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or any similar equity restructuring transaction, as that term is used in Statement of Financial Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor thereto). Notwithstanding the foregoing, the conversion of any convertible securities of the Company will not be treated as a Capitalization Adjustment.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(d)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:8pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Cause</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">will have the meaning ascribed to such term in any written agreement between the Participant and the Company defining such term and, in the absence of such agreement, such term means, with respect to a Participant, the occurrence of any of the following events&#58; (i) the Participant&#8217;s commission of an act of fraud, embezzlement or other act of dishonesty that could reflect adversely on the </font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">integrity, character or reputation of the Company, or that would cause harm to its customer relations, operations or business prospects&#59; (ii) the Participant&#8217;s breach of a fiduciary duty owed to the Company&#59; (iii) the Participant&#8217;s violation or threatening to violate a restrictive covenant agreement, such as a non-compete, non-solicit, or non-disclosure agreement, between a Participant and the Company&#59; (iv) the Participant&#8217;s unauthorized disclosure or use of confidential information or trade secrets&#59; (v) the Participant&#8217;s violation of any lawful policies or rules of the Company, including any applicable code of conduct&#59; (vi) the Participant&#8217;s conviction of, or plea of </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;text-decoration:underline">nolo contendere</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> to, any felony if such conviction or plea (a) results in such Person&#8217;s imprisonment, (b) could reflect adversely on the integrity, character or reputation of the Company or (c) would cause harm to the Company&#8217;s customer relations, operations or business prospects&#59; (vii) the Participant&#8217;s failure to reasonably cooperate in any investigation or proceeding concerning the Company&#59; or (viii) the Participant&#8217;s neglect or misconduct in the performance of the Participant&#8217;s duties and responsibilities, provided that he or she did not cure such neglect or misconduct within ten (10) days after the Company gave written notice of such neglect or misconduct to such Participant. The determination that a termination of the Participant&#8217;s Continuous Service is either for Cause or without Cause will be made by the Company, in its sole discretion. Any determination by the Company that the Continuous Service of a Participant was terminated with or without Cause for the purposes of outstanding Awards held by such Participant will have no effect upon any determination of the rights or obligations of the Company or such Participant for any other purpose.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(e)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:8pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Change in Control</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means the occurrence, in a single transaction or in a series of related transactions, of any one or more of the following events&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(i)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.74pt">any Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the combined voting power of the Company&#8217;s then outstanding securities other than by virtue of a merger, consolidation or similar transaction. Notwithstanding the foregoing, a Change in Control will not be deemed to occur (A) on account of the acquisition of securities of the Company directly from the Company, (B) on account of the acquisition of securities of the Company by an investor, any affiliate thereof or any other Exchange Act Person that acquires the Company&#8217;s securities in a transaction or series of related transactions the primary purpose of which is to obtain financing for the Company through the issuance of equity securities, or (C) solely because the level of Ownership held by any Exchange Act Person (the &#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Subject Person</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;) exceeds the designated percentage threshold of the outstanding voting securities as a result of a repurchase or other acquisition of voting securities by the Company reducing the number of shares outstanding, provided that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of voting securities by the Company, and after such share acquisition, the Subject Person becomes the Owner of any additional voting securities that, assuming the repurchase or other acquisition had not occurred, increases the percentage of the then outstanding voting securities Owned by the Subject Person over the designated percentage threshold, then a Change in Control will be deemed to occur&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(ii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:8.92pt">there is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto do not Own, directly or indirectly, either (A) outstanding voting securities representing more than fifty percent (50%) of the combined outstanding voting power of the surviving Entity in such merger, consolidation or similar transaction or (B) more than fifty percent (50%) of the combined outstanding voting power of the parent of the surviving Entity in such merger, consolidation or similar transaction, in each case in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such transaction&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(iii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:7.1pt">there is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries to an Entity, more than fifty percent (50%) of the combined voting power of the voting securities of which are Owned by stockholders of the Company in substantially the same proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such sale, lease, license or other disposition&#59; or</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(iv)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.64pt">individuals who, on the date the Plan is adopted by the Board, are members of the Board (the &#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Incumbent Board</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;) cease for any reason to constitute at least a majority of the members of the Board&#59; </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">provided, however</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, that if the appointment or election (or nomination for election) of any new Board member was approved or recommended by a majority vote of the members of the Incumbent Board then still in office, such new member will, for purposes of this Plan, be considered as a member of the Incumbent Board.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Notwithstanding the foregoing definition or any other provision of this Plan, (A) the term Change in Control will not include a sale of assets, merger or other transaction effected exclusively for the purpose of changing the domicile of the Company, and (B) the definition of Change in Control (or any analogous term) in an individual written agreement between the Company or any Affiliate and the Participant will </font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">supersede the foregoing definition with respect to Awards subject to such agreement&#59; </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">provided, however</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">, that if no definition of Change in Control or any analogous term is set forth in such an individual written agreement, the foregoing definition will apply.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(f)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.28pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Code</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means the Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance thereunder.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(g)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:8pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Committee</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means a committee of one or more Directors to whom authority has been delegated by the Board in accordance with Section 2(c).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(h)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:8pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Common Stock</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means the common stock of the Company.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(i)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.74pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Company</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means Travere Therapeutics, Inc., a Delaware corporation.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(j)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.74pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Consultant</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means any person, including an advisor, who is (i) engaged by the Company or an Affiliate to render consulting or advisory services and is compensated for such services, or (ii) serving as a member of the board of directors of an Affiliate and is compensated for such services. However, service solely as a Director, or payment of a fee for such service, will not cause a Director to be considered a &#8220;Consultant&#8221; for purposes of the Plan.</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">Notwithstanding the foregoing, a person is treated as a Consultant under this Plan only if a Form S-8 Registration Statement under the Securities Act is available to register either the offer or the sale of the Company&#8217;s securities to such person.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(k)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:8.46pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Continuous Service</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means that the Participant&#8217;s service with the Company or an Affiliate, whether as an Employee, Director or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders service to the Company or an Affiliate as an Employee, Director or Consultant or a change in the Entity for which the Participant renders such service, provided that there is no interruption or termination of the Participant&#8217;s service with the Company or an Affiliate, will not terminate a Participant&#8217;s Continuous Service&#59; </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%">provided, however,</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> that</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:139%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">if the Entity for which a Participant is rendering services ceases to qualify as an Affiliate, as determined by the Board, in its sole discretion, such Participant&#8217;s Continuous Service will be considered to have terminated on the date such Entity ceases to qualify as an Affiliate. For example, a change in status from an Employee of the Company to a Consultant of an Affiliate or to a Director will not constitute an interruption of Continuous Service. To the extent permitted by law, the Board or the chief executive officer of the Company, in that party&#8217;s sole discretion, may determine whether Continuous Service will be considered interrupted in the case of (i) any leave of absence approved by the Board or chief executive officer, including sick leave, military leave or any other personal leave, or (ii) transfers between the Company, an Affiliate, or their successors. Notwithstanding the foregoing, a leave of absence will be treated as Continuous Service for purposes of vesting in a Stock Award only to such extent as may be provided in the Company&#8217;s or Affiliate&#8217;s leave of absence policy, in the written terms of any leave of absence agreement or policy applicable to the Participant, or as otherwise required by law.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(l)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.74pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Corporate Transaction</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means the consummation, in a single transaction or in a series of related transactions, of any one or more of the following events&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(i)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;a sale, lease or other disposition of all or substantially all of the assets of the Company&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(ii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;a sale or other disposition of at least ninety percent (90%) of the outstanding securities of the Company&#59;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(iii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;a merger, consolidation or similar transaction in which the Company is not the surviving corporation&#59; or</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(iv)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;a reverse merger, consolidation or similar transaction in which the Company is the surviving corporation but the shares of Common Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the merger, consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(m)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:5.73pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Director</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means a member of the Board.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(n)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:8pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Disability</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means, with respect to a Participant, the inability of such Participant to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or that has lasted or can be expected to last for a continuous period of not less than twelve (12) months, as provided in Sections 22(e)(3) and 409A(a)(2)(c)(i) of the Code, and will be determined by the Board on the basis of such medical evidence as the Board deems warranted under the circumstances.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(o)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%;padding-left:8pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Dissolution</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">&#8221; </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">means when the Company, after having executed a certificate of dissolution with the State of Delaware, has completely wound up its affairs. Conversion of the Company into a Limited Liability Company (or any other pass- through entity) will not be considered a &#8220;Dissolution&#8221; for purposes of the Plan.</font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(p)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:8pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Effective Date</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means the effective date of this Plan document, which is the date of the annual meeting of stockholders of the Company held in calendar year 2018, provided the Plan is approved by the Company&#8217;s stockholders at such meeting.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(q)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:8pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Employee</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means any person employed by the Company or an Affiliate. However, service solely as a Director, or payment of a fee for such services, will not cause a Director to be considered an &#8220;Employee&#8221; for purposes of the Plan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(r)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:9.84pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Entity</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means a corporation, partnership, limited liability company or other entity.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(s)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:8.46pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Exchange Act</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated thereunder.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(t)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.28pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Exchange Act Person</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">means any natural person, Entity or &#8220;group&#8221; (within the meaning of Section 13(d) or 14(d) of the Exchange Act), except that &#8220;Exchange Act Person&#8221; will not include (i) the Company or any Subsidiary of the Company, (ii) any employee benefit plan of the Company or any Subsidiary of the Company or any trustee or other fiduciary holding securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii) an underwriter temporarily holding securities pursuant to an offering of such securities, (iv) an Entity Owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their Ownership of stock of the Company&#59; or (v) any natural person, Entity or &#8220;group&#8221; (within the meaning of Section 13(d) or 14(d) of the Exchange Act) that, as of the Effective Date, is the Owner, directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the combined voting power of the Company&#8217;s then outstanding securities.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(u)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:8pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Fair Market Value</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means, as of any date, the value of the Common Stock determined as follows&#58;</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(i)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;If the Common Stock is listed on any established stock exchange or traded on any established market, the Fair Market Value of a share of Common Stock will be, unless otherwise determined by the Board, the closing sales price for such stock as quoted on such exchange or market (or the exchange or market with the greatest volume of trading in the Common Stock) on the date of determination, as reported in a source the Board deems reliable.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(ii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;Unless otherwise provided by the Board, if there is no closing sales price for the Common Stock on the date of determination, then the Fair Market Value will be the closing selling price on the next date for which such quotation exists.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%">(iii)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#160;&#160;&#160;&#160;In the absence of such markets for the Common Stock, the Fair Market Value will be determined by the Board in good faith and in a manner that complies with Sections 409A and 422 of the Code.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(v)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:8.46pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Full Value Award</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means a Stock Award that is not an Option or SAR with respect to which the exercise or strike price is at least one hundred percent (100%) of the Fair Market Value of the Common Stock subject to the Option or SAR on the date of grant.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(w)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.65pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Incentive Stock Option</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means an option granted pursuant to Section 5 that is intended to be, and that qualifies as, an &#8220;incentive stock option&#8221; within the meaning of Section 422 of the Code.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(x)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:8.46pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Non-Employee Director</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">means a Director who either (i) is not a current employee or officer of the Company or an Affiliate, does not receive compensation, either directly or indirectly, from the Company or an Affiliate for services rendered as a consultant or in any capacity other than as a Director (except for an amount as to which disclosure would not be required under Item 404(a) of Regulation S-K promulgated pursuant to the Securities Act (&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Regulation S-K</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;)), does not possess an interest in any other transaction for which disclosure would be required under Item 404(a) of Regulation S-K, and is not engaged in a business relationship for which disclosure would be required pursuant to Item&#160;404(b) of Regulation S-K&#59; or (ii) is otherwise considered a &#8220;non-employee director&#8221; for purposes of Rule 16b-3.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(y)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:8.46pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Nonstatutory Stock Option</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means any option granted pursuant to Section 5 that does not qualify as an Incentive Stock Option.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(z)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:8.46pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Officer</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means a person who is an officer of the Company within the meaning of Section&#160;16 of the Exchange Act.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(aa)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:3.44pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Option</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means an Incentive Stock Option or a Nonstatutory Stock Option to purchase shares of Common Stock granted pursuant to the Plan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(ab)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:3.44pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Option Agreement</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means a written agreement between the Company and an Optionholder evidencing the terms and conditions of an Option grant. Each Option Agreement will be subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(ac)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:3.9pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Optionholder</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means a person to whom an Option is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Option.</font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(ad)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:3.44pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Other Stock Award</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means an award based in whole or in part by reference to the Common Stock which is granted pursuant to the terms and conditions of Section 6(d).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(ae)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:3.44pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Other Stock Award Agreement</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">means a written agreement between the Company and a holder of an Other Stock Award evidencing the terms and conditions of an Other Stock Award grant. Each Other Stock Award Agreement will be subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(af)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:5.72pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Own,</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Owned,</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Owner,</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Ownership</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; A person or Entity will be deemed to &#8220;Own,&#8221; to have &#8220;Owned,&#8221; to be the &#8220;Owner&#8221; of, or to have acquired &#8220;Ownership&#8221; of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding, relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to such securities.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(ag)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:3.44pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Participant</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means a person to whom a Stock Award is granted pursuant to the Plan or, if applicable, such other person who holds an outstanding Stock Award.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(ah)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:3.44pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Performance Criteria</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means the one or more criteria that the Board will select for purposes of establishing the Performance Goals for a Performance Period. The Performance Criteria that will be used to establish such Performance Goals may be based on any one of, or combination of, the following as determined by the Board&#58; (1) earnings (including earnings per share and net earnings)&#59; (2) earnings before interest, taxes and depreciation&#59; (3) earnings before interest, taxes, depreciation and amortization&#59; (4) total stockholder return&#59; (5) return on equity or average stockholder&#8217;s equity&#59; (6) return on assets, investment, or capital employed&#59; (7) stock price&#59; (8) margin (including gross margin)&#59; (9) income (before or after taxes)&#59; (10) operating income&#59; (11) operating income after taxes&#59; (12) pre-tax profit&#59; (13) operating cash flow&#59; (14) sales or revenue targets&#59; (15) increases in revenue or product revenue&#59; (16) expenses and cost reduction goals&#59; (17) improvement in or attainment of working capital levels&#59; (18) economic value added (or an equivalent metric)&#59; (19) market share&#59; (20) cash flow&#59; (21) cash flow per share&#59; (22) share price performance&#59; (23) debt reduction&#59; (24) implementation or completion of projects or processes&#59; (25) customer satisfaction&#59; (26) stockholders&#8217; equity&#59; (27) capital expenditures&#59; (28) debt levels&#59; (29) operating profit or net operating profit&#59; (30) workforce diversity&#59; (31) growth of net income or operating income&#59; (32) billings&#59; (33) pre-clinical development related compound goals&#59; (34) financing&#59; (35) regulatory milestones,</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">including approval of a compound&#59; (36) stockholder liquidity&#59; (37) corporate governance and compliance&#59; (38) product commercialization&#59; (39) intellectual property&#59; (40) personnel matters&#59; (41) progress of internal research or clinical programs&#59; (42) progress of partnered programs&#59; (43) implementation or completion of projects and processes&#59; (44) partner satisfaction&#59;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(45)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:139%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">budget management&#59; (46) clinical achievements&#59; (47) completing phases of a clinical study (including the treatment phase)&#59; (48) announcing or presenting preliminary or final data from clinical studies&#59; in each case, whether on particular timelines or generally&#59; (49) timely completion of clinical trials&#59; (50) submission of INDs and NDAs and other regulatory achievements&#59; (51) partner or collaborator achievements&#59; (52) internal controls, including those related to the Sarbanes-Oxley Act of 2002&#59; (53) research progress, including the development of programs&#59; (54) investor relations, analysts and communication&#59; (55) manufacturing achievements (including obtaining particular yields from manufacturing runs and other measurable objectives related to process development activities)&#59; (56) strategic partnerships or transactions (including in-licensing and out-licensing of intellectual property&#59; (57) establishing relationships with commercial entities with respect to the marketing, distribution and sale of the Company&#8217;s products (including with group purchasing organizations, distributors and other vendors)&#59; (58) supply chain achievements (including establishing relationships with manufacturers or suppliers of active pharmaceutical ingredients and other component materials and manufacturers of the Company&#8217;s products)&#59; (59) co-development, co-marketing, profit sharing, joint venture or other similar arrangements&#59; and (60) other measures of performance selected by the Board.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(ai)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.18pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Performance Goals</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means, for a Performance Period, the one or more goals established by the Board for the Performance Period based upon the Performance Criteria. Performance Goals may be based on a Company-wide basis, with respect to one or more business units, divisions, Affiliates, or business segments, and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. Unless specified otherwise by the Board (i) in the Award Agreement at the time the Award is granted or (ii) in such other document setting forth the Performance Goals at the time the Performance Goals are established, the Board will appropriately make adjustments in the method of calculating the attainment of Performance Goals for a Performance Period as follows&#58; (1) to exclude restructuring and&#47;or other nonrecurring charges&#59; (2) to exclude exchange rate effects&#59; (3) to exclude the effects of changes to generally accepted accounting principles&#59; (4) to exclude the effects of any statutory adjustments to corporate tax rates&#59; (5) to exclude the effects of any items that are unusual in nature or occur infrequently as determined under generally accepted accounting principles&#59; (6) to exclude the dilutive effects of acquisitions or joint ventures&#59; (7) to assume that any business divested by the Company achieved performance objectives at targeted levels during the balance of a Performance Period following such divestiture&#59; (8) to exclude the effect of any change in the outstanding shares of common stock of the Company by reason of any stock dividend or split, </font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange of shares or other similar corporate change, or any distributions to common stockholders other than regular cash dividends&#59; (9) to exclude the effects of stock based compensation and the award of bonuses under the Company&#8217;s bonus plans&#59; (10) to exclude costs incurred in connection with potential acquisitions or divestitures that are required to be expensed under generally accepted accounting principles&#59; (11) to exclude the goodwill and intangible asset impairment charges that are required to be recorded under generally accepted accounting principles and (12) to exclude the effect of any other unusual, non-recurring gain or loss or other extraordinary item.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(aj)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.18pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Performance Period</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means the period of time selected by the Board over which the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#8217;s right to and the payment of a Performance Stock Award. Performance Periods may be of varying and overlapping duration, at the sole discretion of the Board.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(ak)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:3.9pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Performance Stock Award</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means a Stock Award granted under the terms and conditions of Section 6(c)(i).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(al)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:6.18pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Plan</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means this Travere Therapeutics, Inc. 2018 Equity Incentive Plan, as it may be amended from time to time.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(am)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:1.17pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Restricted Stock Award</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means an award of shares of Common Stock which is granted pursuant to the terms and conditions of Section 6(a).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(an)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:3.44pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Restricted Stock Award Agreement</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means a written agreement between the Company and a holder of a Restricted Stock Award evidencing the terms and conditions of a Restricted Stock Award grant. Each Restricted Stock Award Agreement will be subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(ao)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:3.44pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Restricted Stock Unit Award</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">means a right to receive shares of Common Stock which is granted pursuant to the terms and conditions of Section 6(b).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(ap)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:3.44pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Restricted Stock Unit Award Agreement</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">means a written agreement between the Company and a holder of a Restricted Stock Unit Award evidencing the terms and conditions of a Restricted Stock Unit Award grant. Each Restricted Stock Unit Award Agreement will be subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(aq)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:3.44pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Rule 16b-3</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule 16b-3, as in effect from time to time.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(ar)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:5.28pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Rule 405</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means Rule 405 promulgated under the Securities Act.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(as)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:3.9pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Securities Act</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means the Securities Act of 1933, as amended.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(at)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:5.72pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Stock Appreciation Right</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">SAR</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%"> </font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">means a right to receive the appreciation on Common Stock that is granted pursuant to the terms and conditions of Section 5.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(au)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:3.44pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Stock Appreciation Right Agreement</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means a written agreement between the Company and a holder of a Stock Appreciation Right evidencing the terms and conditions of a Stock Appreciation Right grant. Each Stock Appreciation Right Agreement will be subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(av)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:3.9pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Stock Award</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means any right to receive Common Stock granted under the Plan, including an Incentive Stock Option, a Nonstatutory Stock Option, a Stock Appreciation Right, a Restricted Stock Award, a Restricted Stock Unit Award, a Performance Stock Award or any Other Stock Award.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(aw)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:2.09pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Stock Award Agreement</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means a written agreement between the Company and a Participant evidencing the terms and conditions of a Stock Award grant. Each Stock Award Agreement will be subject to the terms and conditions of the Plan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(ax)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:3.9pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Subsidiary</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means, with respect to the Company, (i) any corporation of which more than fifty percent (50%) of the outstanding capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether, at the time, stock of any other class or classes of such corporation will have or might have voting power by reason of the happening of any contingency) is at the time, directly or indirectly, Owned by the Company, and (ii) any partnership, limited liability company or other entity in which the Company has a direct or indirect interest (whether in the form of voting or participation in profits or capital contribution) of more than fifty percent (50%).</font></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(ay)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:3.9pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Ten Percent Stockholder</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means a person who Owns (or is deemed to Own pursuant to Section 424(d) of the Code) stock possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or any Affiliate.</font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">(az)</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:3.9pt">&#8220;</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:139%">Transaction</font><font style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8221; means a Corporate Transaction or a Change in Control.</font></div><div><font><br></font></div><div style="height:49.68pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>tvtx-20260519.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e4213-fcc3-7157-ba26-865ef646645a,g:95ac6c5e-3499-45ef-b384-3b61d525bc99-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:tvtx="http://www.travere.com/20260519" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.travere.com/20260519">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2026" schemaLocation="https://xbrl.sec.gov/dei/2026/dei-2026.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tvtx-20260519_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tvtx-20260519_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.travere.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>tvtx-20260519_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e4213-fcc3-7157-ba26-865ef646645a,g:95ac6c5e-3499-45ef-b384-3b61d525bc99-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityTaxIdentificationNumber_019e4213-fcc3-7392-8b3c-dc102e1e12d3_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_019e4213-fcc3-7d19-883a-b8983e38ef12_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_019e4213-fcc3-72ea-84ce-b2ec1aa39232_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_019e4213-fcc3-7b77-9f58-2ec3d72db1b2_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_019e4213-fcc3-716b-85bc-f756bbfddc52_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_019e4213-fcc3-7615-9897-5d7cebaaac91_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_019e4213-fcc3-73c6-a8fd-cc7e973e5fa0_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_019e4213-fcc3-7d92-9356-e26ba3c6edfe_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_019e4213-fcc3-7c14-979a-961487eebc1a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_019e4213-fcc3-739a-998a-237f301e65d8_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_019e4213-fcc3-7efb-8651-447bece7ad4a_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_019e4213-fcc3-716a-9041-cc1b03c37df8_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_019e4213-fcc3-71b9-850c-88811999ea5c_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_019e4213-fcc3-73e0-bb02-114da5934d77_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_019e4213-fcc3-7c5c-8f62-a962666bb3b9_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_019e4213-fcc3-75b7-b3ad-d3b057253181_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_019e4213-fcc3-79ff-bac9-6e220cef3df2_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_019e4213-fcc3-7a4a-bcd0-acb49cbebe82_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_019e4213-fcc3-7e27-9ccc-863014751971_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_019e4213-fcc3-7a71-b34b-d076d91e13d2_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_019e4213-fcc3-7ff7-b5aa-4f0679664a91_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_019e4213-fcc3-7d1e-bae7-2c466f89a0f1_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_019e4213-fcc3-77a0-8853-8415dbcf62c5_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_019e4213-fcc3-739f-b9dc-d435e2b28a72_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>tvtx-20260519_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e4213-fcc3-7157-ba26-865ef646645a,g:95ac6c5e-3499-45ef-b384-3b61d525bc99-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.travere.com/role/Cover" xlink:type="simple" xlink:href="tvtx-20260519.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.travere.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_019e4213-fcc3-7bc3-8448-a5d182b68235" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_DocumentType_019e4213-fcc3-7bc3-8448-a5d182b68235" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_019e4213-fcc3-725e-8626-641db49cea81" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_DocumentPeriodEndDate_019e4213-fcc3-725e-8626-641db49cea81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_019e4213-fcc3-7dd6-bcb0-9e0749a259b9" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_EntityRegistrantName_019e4213-fcc3-7dd6-bcb0-9e0749a259b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_019e4213-fcc3-7b55-a8d8-5460ee536ede" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_EntityCentralIndexKey_019e4213-fcc3-7b55-a8d8-5460ee536ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_019e4213-fcc3-74e8-94d8-bde4fc107011" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_AmendmentFlag_019e4213-fcc3-74e8-94d8-bde4fc107011" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_019e4213-fcc3-76cb-b6a7-008aeabe5d7f" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_EntityIncorporationStateCountryCode_019e4213-fcc3-76cb-b6a7-008aeabe5d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_019e4213-fcc3-7489-880b-7221fbac3071" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_EntityFileNumber_019e4213-fcc3-7489-880b-7221fbac3071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_019e4213-fcc3-77ff-ae95-19676a95b5da" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_EntityTaxIdentificationNumber_019e4213-fcc3-77ff-ae95-19676a95b5da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_019e4213-fcc3-7e41-bb9a-06dc001b1e8d" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_EntityAddressAddressLine1_019e4213-fcc3-7e41-bb9a-06dc001b1e8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_019e4213-fcc3-7d57-95e8-7e0fb4f6de15" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_EntityAddressAddressLine2_019e4213-fcc3-7d57-95e8-7e0fb4f6de15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_019e4213-fcc3-7830-a011-9eb640484a14" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_EntityAddressCityOrTown_019e4213-fcc3-7830-a011-9eb640484a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_019e4213-fcc3-73b2-8a72-9a5d410d1c5f" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_EntityAddressStateOrProvince_019e4213-fcc3-73b2-8a72-9a5d410d1c5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_019e4213-fcc3-7c06-b24a-6a3cc2d5348e" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_EntityAddressPostalZipCode_019e4213-fcc3-7c06-b24a-6a3cc2d5348e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_019e4213-fcc3-7f1a-be78-c671a996a5af" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_CityAreaCode_019e4213-fcc3-7f1a-be78-c671a996a5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_019e4213-fcc3-7cc3-9474-a1635bae2256" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_LocalPhoneNumber_019e4213-fcc3-7cc3-9474-a1635bae2256" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_019e4213-fcc3-745e-95d2-1a7cb425a783" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_WrittenCommunications_019e4213-fcc3-745e-95d2-1a7cb425a783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_019e4213-fcc3-7e60-8cce-410f55eef2c3" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_SolicitingMaterial_019e4213-fcc3-7e60-8cce-410f55eef2c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_019e4213-fcc3-73dc-a5a3-b5b5a06d1c74" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_PreCommencementTenderOffer_019e4213-fcc3-73dc-a5a3-b5b5a06d1c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_019e4213-fcc3-7b6c-b70c-207409541abd" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_019e4213-fcc3-7b6c-b70c-207409541abd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_019e4213-fcc3-7661-b2fc-2bb7799e17d5" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_Security12bTitle_019e4213-fcc3-7661-b2fc-2bb7799e17d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_019e4213-fcc3-7afe-9ecf-ad7f50202771" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_TradingSymbol_019e4213-fcc3-7afe-9ecf-ad7f50202771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_019e4213-fcc3-7deb-9bca-8521982016eb" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_SecurityExchangeName_019e4213-fcc3-7deb-9bca-8521982016eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_019e4213-fcc3-7866-b790-297e0718cf40" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_019e4213-fcc3-71de-b597-7784145b7581" xlink:to="loc_dei_EntityEmergingGrowthCompany_019e4213-fcc3-7866-b790-297e0718cf40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>May 19, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 19,  2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">TRAVERE THERAPEUTICS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001438533<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36257<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">27-4842691<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3611 Valley Centre Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">888<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">969-7879<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TVTX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="tvtx-20260519.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.travere.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="tvtx-20260519.htm">tvtx-20260519.htm</File>
    <File>tvtx-20260519.xsd</File>
    <File>tvtx-20260519_lab.xml</File>
    <File>tvtx-20260519_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2026</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "tvtx-20260519.htm": {
   "nsprefix": "tvtx",
   "nsuri": "http://www.travere.com/20260519",
   "dts": {
    "inline": {
     "local": [
      "tvtx-20260519.htm"
     ]
    },
    "schema": {
     "local": [
      "tvtx-20260519.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2026/dei-2026.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "tvtx-20260519_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tvtx-20260519_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2026": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2026": 23
   },
   "report": {
    "R1": {
     "role": "http://www.travere.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tvtx-20260519.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "tvtx-20260519.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentType",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.travere.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001438533-26-000046-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001438533-26-000046-xbrl.zip
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MG1?)V2S!93^L!6XV=77M5_B^K;*/JZI8&+NVOZ>WR:N'N#+@58O['=VKA[7
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M;O)V17ONR&"6C','%>\X]!Y.3Y(?JJ*H;C!HA;OU=KD$Q0P)\DW:FEE2 N\
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MYN_\@J2K]61$'N'YC= @%9@GJNM5>52<3L^)C&(?;+AF1LXYBT^YQ_4;I'6
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MR71FT3!W4$VO^(NIQX<BYRE7O>R.1UH2L^5$<522<A+@^*FU#X%*2&@RQ)K
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M>_.T_)@L:A"]W!:N-!@K1B\1G)2%XPVRB9Z].L:3&N%1A0H?2'RXL6O@;-?
M=#:N2/&=N=I*0YD/ INSWA;<E%58WP]F@=V870ZS[P0\"[/'7";\WM8 ]ES%
M^"H!JJG&,52#O"'NP>7:Z+I%BNN4,52=!_*Z-M<5L_1<]TR"-P-11IG448 K
M@E1V%GX#ZDGC"A".EHI'2,;S6UMA=AN?SD0H!J5OUF)RHOLEVD8@.QJ.W$^'
M,^2/]2BOQW>2<21C1Q" -:J^>BB;1@+SQ"9)I QH3N>+JBV5D$ZU"_2J#[R
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MBCCU=G]D\TME,KT[7QJ;2QWK$513)G-4GY_$64J>2V!.[E6=;E8SQ=#PEDM
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M+RYP"[R8))>5REUY5/J^U-R/HMU#/, ?P:,ESR\\.^^:\ YG<^<T/L=6O\M
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M)JFWPXW-ED-/'Y]<>3$RB(+7U;4I4TS("S'5'_TGQPE"<'F=YH5"3W]/C.#
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M[\>RN@'MYHI-4O,)<UPLWK#'&J?^Y]L&N]8B##-&NAK=3A6[H9*"B#JCM(%
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M]D-%.8[8SG7&*?8V"5Q(Z)^FKI+)OYU.K>K<3Q/PH",JZFA$N?EI1 -T/"=
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MKDCC4. XI.HFMDAM/;E-7UM4(.*I6,\##Z[T#S%^6V)]W]H8SLU<[H0/(>A
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M]TS"!V]ROK_>)=*7WUT"(W9WVB)C#F6(O=L6)CE[/G_R] AE]NVCS+Y39A.
M5(OXK*/4>6_OH?0Z9A'":/5K]4=([O]\)/?=Y/XS:S=C(6Z;<2Q8RVDYI'[M
MM+U8=IP][PN['R&1I^DXJ/SIR<5($W]'QL$'^"\#HPX*(&3OP.J!E)M!B(L^
MD7#$&>_I_)'R]Z'\Y-("]XWE#NS9.Q%-#><_Y\0P6^IM\5H8L1!_")K_(N>
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M@0LZ3B _GA*7;4V!N@ "1MN>3%:^ -VQ0ER: JY\V])-X._.:/RKFI ;EBS
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M ._D-C?*E\Y8"O=<[O/.U!8Y-J:[#N>(,?C&9CS6H29@AWI!0Z5-LR5ZQK7
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M//"+UA^=BPZY_*UST3KO?+T\;7?! 3]K+_";-J8QAK[G!6S[R%>O *H >GF
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M"WGK[,WFGFSU1W3/WOP/4$L#!!0    ( .F@M5RGM VP_P4  /8R   5
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M96EP+FAT;5!+ 0(4 Q0    ( .F@M5POPM6':A8  "'^   1
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3!@     %  4 2P$  ':4      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>tvtx-20260519_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tvtx-20260519.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001438533</identifier>
        </entity>
        <period>
            <startDate>2026-05-19</startDate>
            <endDate>2026-05-19</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0001438533</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-23">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2026-05-19</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">TRAVERE THERAPEUTICS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-36257</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">27-4842691</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">3611 Valley Centre Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-8">Suite 300</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">92130</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-12">888</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-13">969-7879</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-18">Common Stock, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-19">TVTX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-20">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
